ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000837.1|APE_1 # 1 # 1233 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.397	BGC0000837.1|APE_1 	1	1233	-	Loose	550	45.0542	Nocardia farcinica rox	21.0	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGTTATCACCACAAACAACCCAAGTGGCTATTATTGGTGCTGGACCTTCTGGCTCTATTGCTGCTGCCCTATTAAACAAACACAATATCAACTGCATTATTCTTGAAAAATCGACTTTCCCTCGCTTTTCTATCGGTGAAAGTTTATTACCTGCATGTATGGAATCCATTAAACATGCAGGCATGTTAAACGCTGTTGAAGATGCTTGTTTTCAATTCAAAGATGGTGCTGCATTTCATTGTAATGGCACTTTCACTTCTTTTGATTTTACGGACAAATTCACCGACGGCGCAGGAACCACATTCCAAGTACAACGTGGCAACTTTGATAAAGTTTTAGCTGATTGTGCAAAAGAACAAGGCGTTGAAATTCGCTATCAGCATGAAATAACCGATGTGGATGTAAATGCAGAAAAGCCTCTATTATCGGTACTGGATGAAAACGGAACGCCTTACCAAATTCAAGCAGATTTCATTCTTGATGCGAGTGGCTTTGGCCGTGTTCTACCAAAATTATTGGAATTAGAAGAGCCCTCATGTCTGCCACCACGCCGTGCTATTTTTACACATATAAAAGACAATATTACTGACGAAAGCTACGACAGAAATAAAATTTTAGTCTCTGTTCATCCAACAAATACACAAGTGTGGTATTGGTTAATTCCATTCAGTAATGGGACCTGCTCTTTTGGTGTGGTTGGAGAGCCTGAGTTCTTCGATGCATATTCAGAAGATAAAGTAACGGCATTAAAACAACTTGCAGAAGAAGAAAGTAATCTCAAACATCTGTTAAACCAAGCTGAATACCCGAACCCTTGCGGTGAAATCATGGGCTATTCTGCCAATGTCAGTAAGCTGTTTGATAAAAACTTTGCTTTACTGGGCAATGCTGGTGAATTTTTAGATCCGGTGTTCTCTTCTGGTGTCACGATTGCAATGAAATCGGCAGAGCTAGCTGCAGACTTATTGATTAAGCAATTTAATCAAGAAGACGTTAATTGGCAGCAAGATTACTCAGATAAGTTGATGAAAGGAGTCAATGCTTTTCGTTGTTACGTAGAAGGATGGTATGAAGGGACATTCCAAGATGTGATCTTCCATGAAAATCCGAATCCTAAAATTAAACAAATGATCTGCGCCATTTTAGCTGGCTATGCTTGGGATGAAAGCAATCCATTTGTTGCCGAGCCAGAGCGTCGATTAAAAGTGGTTGCTGAATTATGTAAGCCATAA	MLSPQTTQVAIIGAGPSGSIAAALLNKHNINCIILEKSTFPRFSIGESLLPACMESIKHAGMLNAVEDACFQFKDGAAFHCNGTFTSFDFTDKFTDGAGTTFQVQRGNFDKVLADCAKEQGVEIRYQHEITDVDVNAEKPLLSVLDENGTPYQIQADFILDASGFGRVLPKLLELEEPSCLPPRRAIFTHIKDNITDESYDRNKILVSVHPTNTQVWYWLIPFSNGTCSFGVVGEPEFFDAYSEDKVTALKQLAEEESNLKHLLNQAEYPNPCGEIMGYSANVSKLFDKNFALLGNAGEFLDPVFSSGVTIAMKSAELAADLLIKQFNQEDVNWQQDYSDKLMKGVNAFRCYVEGWYEGTFQDVIFHENPNPKIKQMICAILAGYAWDESNPFVAEPERRLKVVAELCKP	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	86.68	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	630	rifampin
BGC0000837.1|APE_3 # 2504 # 3079 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.337	BGC0000837.1|APE_3 	2504	3079	-	Loose	2000	26.1794	oqxB	45.83	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCATTTTTAAAACCATTATTAGCGACTTCCGGTTTAATAATTTTATCGGGTTGCGCGAGTGTCATGACTCTTACTGACAAAAATACGGGTGACGATTTATTTCTTACCAATAAACCCGTTTATACTCTTGTTAACCTTCACCCTGACGACACTCGCTCAAAACTTTATTCTGTTAATTTTCAACAAGATGGATTAATCCCTCTCTGTACTCAAGTTGATATTGTCAACGTTAGTACTAAACGTCTTACATTTAAAATTGATAGTAGTGGCAGAGAATATATTTTAGATAAACACAAATCATCTCCTGATTTTGCAAAATACTTAAGCAACTATTTCGGTACTGAGTGTAATACTGAAAAAGTAGAAAAACTAAGTGCACTTGATCAGCAGGGAATAAAAGAAGGTGTGGTTAAGAAAGGCATGACAAAAGAAGGCGTAAAATATGCCATCGGCTTCCCACCAGAACATAGAACACCTAATTTAAATAGCGATCATTGGTTATATTGGAAAAATAGATTTAATACTTTTAAAGTCGAATTTAACGGTAATACCGTATCAAATATAATCGATTAA	MSFLKPLLATSGLIILSGCASVMTLTDKNTGDDLFLTNKPVYTLVNLHPDDTRSKLYSVNFQQDGLIPLCTQVDIVNVSTKRLTFKIDSSGREYILDKHKSSPDFAKYLSNYFGTECNTEKVEKLSALDQQGIKEGVVKKGMTKEGVKYAIGFPPEHRTPNLNSDHWLYWKNRFNTFKVEFNGNTVSNIID	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	18.19	gnl|BL_ORD_ID|2152|hsp_num:0	2400			1785	1857	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0000837.1|APE_4 # 3218 # 3937 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=3-4bp;gc_cont=0.388	BGC0000837.1|APE_4 	3218	3937	+	Loose	275	30.4166	AAC(6')-I-48	29.11	3004638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACATACGCAAATTTTAATATTATCGATTGGCACGCAATTTCTGCAGGTTTGGATAGCAAAAATGCGTGGTTAGAATGGCGTGAAAATAATTTCACTTGGCCTGAAAATGAAAAAGCGCCAGTTGATAAAATACCAGCAATGGCTCGAAGAAGAATGAGCTCGTTAAGTAAATTAGCCGTGCAAACCGCATTAACATTAGCGGAAGAAAATGACATTGATTATTTGGTGTTCTCTAGTCAACATGGTGAGTTAACTCGAACTGTCGCTCTTTTAGAAGATATTTTGAATGGAGATGATGCTTCTCCAATGGCTTTTTCTCAATCGGTTCATAATACTGCCGCAGGTCTATTTACCATCACGGCCAAAAAAGCCATTCCAGTTACTTCTATCGCTGCTGGGGAAAATACCTTTCATTCTGCGGTTGTTGAAGCCGCTGCGTACTTAGCTGAAAATCAAAATAACAAAGTTCTCATTATCGACTTTGACGAGCCTTTACCTTCTCATTACCAAGAGTTTGAAAAACAAAACTATCAAGGCTATGCAGTTGGCTTAATAATGAGCGCTGGTGACATTTTTTCTCTTCAATGGAACAATAAACCTACAATTAAACCTTCTGGATTGCCTCATGGGTTGCAATGTATAGCTAACTTAGTAGGATCACACTCTCAATGGATAACGGAGAGTTCTTCAAAACAATGGGTATGGAATCGAAAATAG	MTYANFNIIDWHAISAGLDSKNAWLEWRENNFTWPENEKAPVDKIPAMARRRMSSLSKLAVQTALTLAEENDIDYLVFSSQHGELTRTVALLEDILNGDDASPMAFSQSVHNTAAGLFTITAKKAIPVTSIAAGENTFHSAVVEAAAYLAENQNNKVLIIDFDEPLPSHYQEFEKQNYQGYAVGLIMSAGDIFSLQWNNKPTIKPSGLPHGLQCIANLVGSHSQWITESSSKQWVWNRK	MSKLGPTKPAPSMANTPVGNVVPCKTPDHPGWLELRLQLWPDGSTEEFLPEMAAACAEPDRFGQFLFLSPGGLAEGLVEVALRTDYVNGTESSPVAFLEGVFVVPASRGLGIARALVAAAEGWARDRGCTEFASDAEVSNVGSHAMHAALGFVETERVVFFRKVVAP	143.11	gnl|BL_ORD_ID|4965|hsp_num:0	3338			150	366	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000837.1|APE_5 # 3942 # 4739 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.373	BGC0000837.1|APE_5 	3942	4739	+	Loose	750	25.7942	PDC-85	26.98	3004348	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGACTTTACTTCAACGCACTGATAAATACTGGCGAATTTTAGCTACTGGGTTCTGTTTCTCTTTATTCGGAGTCGGTGCACTTTGCTTGACGTTTATTGTTTTTCCATTACTTACATTTACTGTAAAAGATAAAAAACAACGAGAAGTTCGAGTGCAATCGATTATCCAACGTAGTTTTTTTATCTTTTGTAAAACAATGCACTATAGTCGTGCGATTAAGTATCAATTTGATGGTGCAGAGCTTCTTCAGAGTGACAGAAATTGCTTAATTGTCGCTAATCACCCAAGCTTAATAGATTATGTTTTAATTGCTTCACAATTGAAGCAATGCGATTGCATCGTAAAAGCAGCCTTATGGCATAATCCGTTTACACAAGGGATTGTCAGAGCTGCGGGGTACATTCCAAATCAAGAACCAGAAGCGTTTTTAGAAGAGTGTTCTGAAAAATTAAACTCAGGTAATGTATTGTTGGTTTTTCCTGAAGGAACGCGAACAACACCGGGTAAAAAATCAAAACTTCAACGAGGTGCAGCGCAAATTGCGGTTCGTAGTCAAAGTGATATTCGTATTATTCATATCACAGTAACACCCAGCTTTTTAACTAAAGAAGCAAAGTGGTATCAAGTTCCTGATGTTCGCCCTTTCTTTCATTTACAAGTGAAAGAGAGAGTCGCCATCACTCCATTTATCGAAGACGCTGACTCTTCATCTTCAGCGGCTCGAAATGTAAATCGATTTTTAGATACAGCTTTGTATCCACAAAATGAAGTCAACACATCAAAAGAAAATAAGTAG	MTLLQRTDKYWRILATGFCFSLFGVGALCLTFIVFPLLTFTVKDKKQREVRVQSIIQRSFFIFCKTMHYSRAIKYQFDGAELLQSDRNCLIVANHPSLIDYVLIASQLKQCDCIVKAALWHNPFTQGIVRAAGYIPNQEPEAFLEECSEKLNSGNVLLVFPEGTRTTPGKKSKLQRGAAQIAVRSQSDIRIIHITVTPSFLTKEAKWYQVPDVRPFFHLQVKERVAITPFIEDADSSSSAARNVNRFLDTALYPQNEVNTSKENK	GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGHGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	71.43	gnl|BL_ORD_ID|2472|hsp_num:0	2864			564	729	
BGC0000837.1|APE_6 # 4747 # 5004 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.376	BGC0000837.1|APE_6 	4747	5004	+	Loose	275	22.7126	vanE	22.22	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGGAAGTATTACACAACGAAATTAAACAATTAATTATTGACGCTCTTAACCTAGAAGATATCTCTGTTGATGATATTGAAACCGAGGCACCGCTATTTGGTGACGGCTTGGGCTTAGATTCTATCGATGCTCTAGAGTTAGGTTTAGCAATTAAGAAAAAGTACAACTTAGTGTTAGATGCTGACGATACTCAAACTCGTGAACATTTTGCGTCAGTAGCAAACCTAGCCGCTTACATTAATGCAAACAAAGCGTAA	MEVLHNEIKQLIIDALNLEDISVDDIETEAPLFGDGLGLDSIDALELGLAIKKKYNLVLDADDTQTREHFASVANLAAYINANKA	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	24.15	gnl|BL_ORD_ID|1478|hsp_num:0	1617			351	540	vancomycin
BGC0000837.1|APE_7 # 5016 # 5273 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.368	BGC0000837.1|APE_7 	5016	5273	+	Loose	1250	22.7126	mecA	38.46	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGACAGACGTAAATAAAGAGCAAGTATTAGAGCAAGTAACTTCTGCATTAGTTGAACTGTTTGAAATTGATGAAGCAGATATTACCCCAGAAGCTCAGCTGTATACTGACCTTGATTTAGATAGTATCGATGCTGTCGATCTTGTTGTTCATTTGCAGAAAGTGACGGGTAAAAAAATCAAACCAGAAGAGTTCAAAGAAGTTCGTACTGTTGACGATGTAGTTAATTCTGTAGCTGCACTGTTAAAAGGCGAATAA	MTDVNKEQVLEQVTSALVELFEIDEADITPEAQLYTDLDLDSIDAVDLVVHLQKVTGKKIKPEEFKEVRTVDDVVNSVAALLKGE	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	12.72	gnl|BL_ORD_ID|1216|hsp_num:0	1321			822	939	methicillin
BGC0000837.1|APE_9 # 5830 # 7197 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.401	BGC0000837.1|APE_9 	5830	7197	+	Loose	1000	55.4546	almE	22.85	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAAAACAGTCTCTCTTTCGCAATTAGTATTACAAGATAAAACAGACCACACGGTGTGTTTTGATGAGCAGCACTCATATATTTCTTATTCTCAATTTCAAAAAGACGTTCAGAAAGCGTGTGCCTTTTTTCAGCAGCAACCTCACACTAAGTGGGCATTGTGTTTTGATGACAGCTATTATTTTTCGGTTACTTTTCTTGCATTAGCCCATGCGGGTAAACACCTTATTCTTCTAGGTAATCATCAACCAGCGGCATTGGCCGAATTATCTCAGCATTTTGATGCCTTAATTCATGATGACATTATTAAAGTGATGCCATGCAGTGAGCATGTTGCCTATCATGATATAAAAAGTGACCATTTAGCTACATTATCACCACTTCCTCTTCATGAGGTTGAGCTTACTTTATTTACTTCTGGCTCAACTGATACACCCAAGCCCATTGCTAAAAACCTTCAATTACTTGATAACGAAATTCAACAATTAGACTGTTTATGGGGTGAAAAACTCGGACAAAGTGACATTTACAGCACCGTATCACACCAACATATCTATGGTTTATTATTTAGAGTGTTGTGGCCATTAACGGCTGGTCGTGCCTTTAGTCGCCATAACTTTATCTACCCAGAGCAGATTTTATCTCATCGACCAGATGATAAAAAAACGCTTATTTCTAGTCCCGCATTGCTTAAGCGCTTGGTTGATCACGAAGGGTACAATGGCTATCAGATGGTTTTCTCTTCCGGCGGACCTCTTGCTATTGAAGGGGCTGAGCAAAGTGAGAAAAAACTCTCACTGCGTCCATTTGAAGTTTATGGTAGTACAGAAACAGGTGGTATTGGCTACCGTCAGCAGTTTGAACCAAGCTCTTTATGGTGCTTCTTTCCTTCTCATCAAGCTCGTTTAAACATTGAACATTGCTTAGAATTGCTTTCTCCATTTATTGATGACGAAGAGTGGTACGCGACGAGCGATTACTGTGATTTGCTTGCTAATGGTCAGTTTGTTCTAAAAGGTCGCGTCGATCGCGTGATCAAAATTGAAGAAAAGCGCCTCTCTTTAACGGAAGTTGAAAAACGATTAATGCAGTTAGAGTGGATTAATGAAGCGGCAGTGATCCCGATGGAAGAAGAAAAACGCACCGTATTGGGCGCAGTGATTGTTCTATCAGAAGCAGGAACTAAACTAATGGAGCAGGGCTCTAAGGGTAAGTTTTGGTTGAGATTACGCTCAGAATTACGTGAATGGTTAGAGCCTGTTGGTATTCCTCGTCGTTTTAGAACTGTTAGTGAAATTCCATTAAATAGCCAAGGTAAACGTCAAATGCACGATTTAAAGCAGCTATTTAATGATGCGAATAATTAA	MKTVSLSQLVLQDKTDHTVCFDEQHSYISYSQFQKDVQKACAFFQQQPHTKWALCFDDSYYFSVTFLALAHAGKHLILLGNHQPAALAELSQHFDALIHDDIIKVMPCSEHVAYHDIKSDHLATLSPLPLHEVELTLFTSGSTDTPKPIAKNLQLLDNEIQQLDCLWGEKLGQSDIYSTVSHQHIYGLLFRVLWPLTAGRAFSRHNFIYPEQILSHRPDDKKTLISSPALLKRLVDHEGYNGYQMVFSSGGPLAIEGAEQSEKKLSLRPFEVYGSTETGGIGYRQQFEPSSLWCFFPSHQARLNIEHCLELLSPFIDDEEWYATSDYCDLLANGQFVLKGRVDRVIKIEEKRLSLTEVEKRLMQLEWINEAAVIPMEEEKRTVLGAVIVLSEAGTKLMEQGSKGKFWLRLRSELREWLEPVGIPRRFRTVSEIPLNSQGKRQMHDLKQLFNDANN	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	81.83	gnl|BL_ORD_ID|4935|hsp_num:0	5928			579	1635	colistin A; colistin B
BGC0000837.1|APE_10 # 7211 # 7585 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.371	BGC0000837.1|APE_10 	7211	7585	+	Loose	200	24.6386	vanX gene in vanF cluster	41.38	3002952	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGATAAAACGTAAGCCAAGTATCCTTACAACAAAAGATATCTCAGTAAATGAAGCGCAACCAAGTGTGCTTATTTGTATGCGTGTGGATGATGATATCTTAGACTTCACCGGACACTTTCCAAATCATCCTTTGTTACCCGGTGTTACTCAAGTTGATTGGGCTATTCATTATGCGAAACATTACCTTAATGCGCATTCAAACTTTAAAGGAATGGAAGTACTTAAGTTTCAAGAACCTATTTTACCGAATATGGAAATAGAACTTGAGCTTAAATGGGATATTGAGAAGAGTAAGCTGTATTTTACTTACCGCTCAAATAAAGGCGATACGGTAAGCAATCATGCTTCTGGTCGTATTGTGTTAGGAGCGTAA	MIKRKPSILTTKDISVNEAQPSVLICMRVDDDILDFTGHFPNHPLLPGVTQVDWAIHYAKHYLNAHSNFKGMEVLKFQEPILPNMEIELELKWDIEKSKLYFTYRSNKGDTVSNHASGRIVLGA	MEKDFVFLDEILHGVRWDSKYATWDNFTGKPVDGYEVNRIAGTYALAVALLEVKKQAAALGYGLLLWDGYRPQRAVNCFLHWSAQPEDGRTKERYYPNIDRIEMVTKGYVASKSSHSRGSAIDLTLYRLDTGALVPMGSGFDFMDERSHHTSKGISSNEAQNRQLLCSIMEYSGFESYVYEWWHYVLRNEPYPSSYFDFPIGGNHLDPFSNFCGTVPLDALSP	55.61	gnl|BL_ORD_ID|1499|hsp_num:0	1509			450	522	vancomycin
BGC0000837.1|APE_11 # 7588 # 9279 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.392	BGC0000837.1|APE_11 	7588	9279	+	Loose	550	53.9138	PmrF	31.3	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACTAACTTTCGCCCTTGTTTTTTAATTCCTTGTTATAACCATGGTAAAACCATTCCTGCCGTTGTTGAATCATTGATGTCGTATGGTTATCCAATGATCATCGTTGATGATGGCAGTGAGAATGAAACAAAGCGTATTTTAGAAGAAGTAACTCAACATAATGAGTCAATTACCTTAATCACATTGGCTGAAAACCAAGGTAAAGGTGGGGCTGTGATTGCTGGTATCGAAAAAGCCTATCAGCAGAGTTACAGTCATGCGATTCAAATTGATGCTGATGGTCAACATGATCTCGAAGCGCTACCTAAATTAATCGCTGAATCTCAAGAACACCCAACGGCACTGATTTCTGGACAGCCTATTTACGATGAGAGTGTACCTAAATCTCGTTTGTATGGTCGCTATGCTACGCATATTTGGGTGTGGATTGAGACACTTTCTTTTACCATTAAAGACAGTATGTGTGGTTTCCGCTCTTATCCTATCGGTCCAACGATTAACGTATTAGAGCGAGCGGTGCTTGGCCGACGAATGGATTTTGATACCGAAATCATGGTTCGTATGTACTGGAATGAAACCGATATTCGCTTCATCAATACTCGTGTTATTTACCCAGAGGATGGCATTTCTCATTTTGATGCATTATGGGATAACGTGAAAATCAGTTGGATGCATACCAAATTATTTTTTGGCATGCTGCCTCGTATTCCGTCATTACTAAAACGTAAACCTGTTCAAGAAGATCATTGGTCGTCTCATGCTGAGCGCGGTACGATTTTAGGTATTCAATTTTTACTTTGGATCTATTCAACGTTTGGTCGCAAGGTATTTTCACTATTACTCAAACCAGTCATGGCTTATTACTACCTACGTGGTGGTTCAGTCAAAGACGCTTCTGATGATTTCATTCAACAGGTAAATGCTTATGCTCGAATTAAAGGCATTCAATTACCTGAAAAGCTAACCACTTATCGTCATTTGGTCTCTTTTGGTGAAACCATGTTAGATAAGCTTGCGGCATGGCGTGGTGATTTTTCAGATAAAAACTTAACGGTTCATGGTATTGAGCATTATCAAACATTAGCTCAGCGTGAAAAAGGCATTGTATTATTGGGTTCTCATTTAGGAAATCTAGAACTATGTCGTGCGCTTAGCCGTCGTCATACTCACCTGAAGATTAATGCGTTAGTTTTTACTGAGCATGCAGAGCGTTTTAATACGGTAATGAAAACCGTTAATCCGCAATCAGAAGTGAATGTTATTCAGGTGTCTAAAATAGGGCCAGATACCGCCATTTTATTGCAGCAAAAAATTGATGATGGTGAGTGGATTGTTATCGTTGGTGATAGAACGTCAGTCACTAAAGAGAATCGAGTGATTTGGGCTGATTTTCTTGGTAAGCCTGCGCCATTTCCTCAAGGGCCATTTATGTTGGCCTCTATTTTAAAGCAACCAGTATATTTAATGTTTGGGCTTCGTGACGATACACAAAAAGATCCGTTGTTTGATGTGTATTTAGAACCGTTTTCTGAACAAATCATATTACCTCGTGGTAAGCGAGAAGAGGCTTTGCAAGAAGTCGTACAAAATTATGCTCAACGTCTAGAGCATTTCACATTAAAAGCACCATCACAATGGTATAACTTTTTTAATTTTTGGCAGTTAACTGGAAAGAAAGATGACAACTAA	MTNFRPCFLIPCYNHGKTIPAVVESLMSYGYPMIIVDDGSENETKRILEEVTQHNESITLITLAENQGKGGAVIAGIEKAYQQSYSHAIQIDADGQHDLEALPKLIAESQEHPTALISGQPIYDESVPKSRLYGRYATHIWVWIETLSFTIKDSMCGFRSYPIGPTINVLERAVLGRRMDFDTEIMVRMYWNETDIRFINTRVIYPEDGISHFDALWDNVKISWMHTKLFFGMLPRIPSLLKRKPVQEDHWSSHAERGTILGIQFLLWIYSTFGRKVFSLLLKPVMAYYYLRGGSVKDASDDFIQQVNAYARIKGIQLPEKLTTYRHLVSFGETMLDKLAAWRGDFSDKNLTVHGIEHYQTLAQREKGIVLLGSHLGNLELCRALSRRHTHLKINALVFTEHAERFNTVMKTVNPQSEVNVIQVSKIGPDTAILLQQKIDDGEWIVIVGDRTSVTKENRVIWADFLGKPAPFPQGPFMLASILKQPVYLMFGLRDDTQKDPLFDVYLEPFSEQIILPRGKREEALQEVVQNYAQRLEHFTLKAPSQWYNFFNFWQLTGKKDDN	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	174.84	gnl|BL_ORD_ID|1937|hsp_num:0	2014			36	357	polymyxin B
BGC0000837.1|APE_12 # 9269 # 10804 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.409	BGC0000837.1|APE_12 	9269	10804	+	Loose	350	26.1794	vanM	30.95	3002911	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGACAACTAATTCAATTACATTTGGTAAAGGACGTCTGACAATTGAAGACGTTGTTGATATTGCAAATGGTGCAAATGCACAACTTAATAATTCTGATGAATTCACTGCCAAAATTGACCGTGGTGTTGAGTTTTTAGAACGTTTATTAAAAGAAGAAGGCGTGATCTATGGTGTAACAACGGGTTATGGTGACTCTTGTACTGTAGCAATCCCAATGGATTTAGTGGATGAATTACCGCTGCATTTAACTCGTTTTCACGGTTGTGGTTTAGGCGAAAACTTAGATGAACAACAAGCACGTGCTGTATTAGCGACTCGCTTATGCTCTTTATCACAAGGGGTATCGGGTGTGACTCATGATCTGCTTAATCAAATCGTGACTCTAATTAATCACGGCGTATCTCCACGTATTCCTCAAGAAGGTTCTGTGGGTGCAAGTGGTGATTTAACGCCATTATCTTATCTTGCTGCTGCCCTTATTGGTGAGCGTGAAGTGATTTATAAAGGTGAAATCCGTGCAACTGCAGATGTATTTAAAGAGCTAAATATCACACCAATCAAGCTTAAACCAAAAGAAGGTTTGGCTTTAATGAATGGTACATCAGTGATGACAGCGTTAGCGTGTTTAGCATATAAGCGTGCTGAGTACTTAGCGCAAATGGCAACTAAGATCACCGCAATGGTATCGGTAGGGATGCAAGGTAATGACTTCCACTTTGATGAAGCGTTATTTGCGGTGAAACCACATCCAGGCCAACAACAAATTGCTGCTTGGTTACGTTCTGATTTACATAACGAAACACCACCAAGAAACAGTGATCGTCTGCAAGACCGTTACTCACTTCGTTGTGCTCCACATGTGATTGGTGTACTTCAAGATAGCCTACCGTTCTTGCGTCAAATGATTGAAAATGAATTAAACAGTGCGAACGATAACCCAATTATCGATGGTGATAATGAGCGTGTTCTTCACGGTGGTCATTTCTATGGTGGTCATATTGCAATGGCAATGGACATGCTAAAAACCGCAGTAGCAAATATTGCTGATTTATTAGATCGCCAAATGGCACAGCTAATGGATTACAAATTCAATAACGGTTTACCATTTAACCTGACGGGGTCAACAGGGGCTCGTAAACCAATTAACCATGGCTTTAAAGCGGTTCAGATTGGTATTTCAGCATGGACAGCAGAAGCGCTTAAAGGAACAATGCCTGCAAGTGTTTTCTCACGTTCAACAGAATGTCATAACCAAGATAAAGTGAGCATGGGTACGATTGCCTCTCGTGATTGTTTACGTGTTTTACAGTTAACAGAGCAAGTGACATCAGCTTCATTATTAGCGGCAACTCAAGCGTTAGTATTGCGTGAAAAGCAAGGTGAGCTTGATGATACTCAGTTAAGTAAAGAGCTTAAAACCATGCGTGATGCGGTATTAAGTGAATTTGCTTTTGTCGATGAAGACCGACCATTAGAGAACGATTTACGTAACTTTATGGCGAAGATTCAGCAACAGCACTGGACACTATACTAA	MTTNSITFGKGRLTIEDVVDIANGANAQLNNSDEFTAKIDRGVEFLERLLKEEGVIYGVTTGYGDSCTVAIPMDLVDELPLHLTRFHGCGLGENLDEQQARAVLATRLCSLSQGVSGVTHDLLNQIVTLINHGVSPRIPQEGSVGASGDLTPLSYLAAALIGEREVIYKGEIRATADVFKELNITPIKLKPKEGLALMNGTSVMTALACLAYKRAEYLAQMATKITAMVSVGMQGNDFHFDEALFAVKPHPGQQQIAAWLRSDLHNETPPRNSDRLQDRYSLRCAPHVIGVLQDSLPFLRQMIENELNSANDNPIIDGDNERVLHGGHFYGGHIAMAMDMLKTAVANIADLLDRQMAQLMDYKFNNGLPFNLTGSTGARKPINHGFKAVQIGISAWTAEALKGTMPASVFSRSTECHNQDKVSMGTIASRDCLRVLQLTEQVTSASLLAATQALVLREKQGELDDTQLSKELKTMRDAVLSEFAFVDEDRPLENDLRNFMAKIQQQHWTLY	MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWDNEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYVGCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYGVNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGIFRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGRIVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVKE	148.98	gnl|BL_ORD_ID|1774|hsp_num:0	1924			546	657	vancomycin; teicoplanin
BGC0000837.1|APE_13 # 10816 # 11262 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.405	BGC0000837.1|APE_13 	10816	11262	+	Loose	800	25.7942	PDC-231	30.95	3005304	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGACTAATACAAATGAAGCTAAGCCAGTGAATGTATTAAGCGCAGAAGTGATGATCACAACCGCCTTTCAGGATGCGGATCCGATGGGAGTTGTGTATCACGGTAATTATTTCCGATTTTTTGAAAAAGCACGTCATGAAATGCTTGAAAAAATCGGTTATAGCTACCGAGATATGATGGCGTCAGGCTATGTTTGGCCCATCATTGACACTCGTGTTAAGTACGTTAAATCCATTCCTTACGATCATAAGATCCGAGTGGAAGCGACACTAACGGAATGGGAAAACCGCATGCGTGTTGATTATGTTATCTATGATGCAGAAACCAACGTACGAATGACTAAAGCCCATACAATGCAAGTAGCGGTAAGCATAGAAACTGAAGAAATGTGCTTTGTTTCTCCTCGTATATTTACCGATAAAGTAGAGGCTTATCATAATGCTTAA	MTNTNEAKPVNVLSAEVMITTAFQDADPMGVVYHGNYFRFFEKARHEMLEKIGYSYRDMMASGYVWPIIDTRVKYVKSIPYDHKIRVEATLTEWENRMRVDYVIYDAETNVRMTKAHTMQVAVSIETEEMCFVSPRIFTDKVEAYHNA	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	37.56	gnl|BL_ORD_ID|3008|hsp_num:0	4036			840	966	
BGC0000837.1|APE_16 # 12397 # 14292 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.397	BGC0000837.1|APE_16 	12397	14292	+	Loose	1800	31.5722	mdtC	25.76	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGGGAGGGGAGTTAGAGAACGATCCTTTCTTGTTATTTCGAGATTATTTATCAGGGTTAACTCAAAGCTCTGGTAATGTTCAAGTAGAGAATGGCTATCTGATTGCCAAGCACGATGATAAAGAATATGTCGTGATCACCGCTGATCTATCAGGATCATCATACCAACTCTCTTTGCAGCAGCAATTACCTCAACTATTGTCACTTGAAAGCAAAGTATCAAAGACATTTTCGGTTGATATTCAACATACAGGTGTGATCTTTTATGCAGCCCATGGGACAGAAAGCGCCAAAGGGGAGATCAGCACAATCGGCCTTGGATCCCTTATCGGAATTATTGTCCTTGTCTTTTTAGTTTATCGCAGCACATTACCTTTGGCTCTAGCATTACTGTCAATATCAACGGGTCTTGCTTGTGCCTATGTACTGACGATTGCTTTATTTGGTTCCATTCATTTGTTTAGTTTGGTTTTTGGTGCCAGCTTAATTGGGGTTTCTATTGATTATGCATTTCACTTTTTAACCGACCGACTTCATGCGGGCAAAAAATGGAATTCAGTGGTGGGTATTCAGCAACTGTTTCCAGCCATTACCTTGGGGCTAATTACCAGTTTAATTGGTTATTTAGGGATGCTTATTGCGCCTTTTCCCGGGTTACAGCAATTATCCTTATTCTCCGCCATTGGTTTAACGGCAGCCTATTTTACAGTGGTATGCTGGTATCCAATATTGGCAAGTAAACCAAATCAATATAACAAAGTACCGATGCAACGAGCCTTGAGTCAGTGGCTCTTGGTGTGGCAACAACCGCTTATTCGATTAGTTTTACCATTGAGCTTATTGATTGCTGCAAGTTTTGGTGTCTATATGGCGAAATATGATGATGATATTCGTCAACTTCAAGCTTTGCCACATGCACTGCAGCAGCAAGAGAGAGAGATAAAAGCGATTACCGGTGTCAGTGGCTCTCAGCAACTATTGCTTGTACGAGACAGCTCTGAAGAAGGGTTACTGCAAAAGTTAGAAACCATATCGACTAAACTGGATAAACGTAATGATTTCGGTGGTTATCAATCCATAAGCCGTTATGTACCGTCACAAAAAAGACAACAAGAAAATTACCAATTAGTTAAACACCTGTATCAGCAACAATCTGAGTATTATCAAAGTGTCATACAGCAAAAAACAGCGCTGGATTTTTCACAGCAATATCAGCCTCTGACTATAGATGGTTTCTTAGCGTCACCAATATCAGACACAGTGGGTTTTTTATGGTTAGGCAAAATTGATGATGTATTTGCCTCGGTGATCGCGTTTAACCAAGAAGTGAACAGTACGGAACTGCAAGCATTTGCAGCGGATAATCACATTACTTATTTAAATAAAGCAGAAGAGATTTCTCGTTTATTTGCAGATTATCGACATCGTATTACCGAGCTATTGTTGTTTGCTTATGCCGCTATTTTCTTACTGCTGTTACCTCGCTATAAAATGAAACAAGCGTTTTTAATAGTATTGCCACCATTTATAGCAGGTTGCGCCGGTTTAGCTGTAACCGTTTTAACTGGCGTACCGTTGAATTTGTTTAACTTACTAGCCTTGATGTTGATTTTAGGGATCGGAATAGACTACACCTTGTTTTTTGCAGAGCAGAATAAGCAAAGTGATGATTCACATAAAGAAAGCACGCTATTAGCGATATCTTTATCTGCGTTAACAACGATTTTGTCATTTGGTTTATTGGCTTTGAGTGAAACCCAAGCGATTCATAGCTTTGGTATTACGGTTCTTACAGGGATTATCGTGGCTTGGTTACTGGCTCCGTTAAGCCAACAAAATAAAGAGAGTAAAGGGTATATTAATACGCTTTCGGAGAAAAAAGATGCATCATAA	MTGGELENDPFLLFRDYLSGLTQSSGNVQVENGYLIAKHDDKEYVVITADLSGSSYQLSLQQQLPQLLSLESKVSKTFSVDIQHTGVIFYAAHGTESAKGEISTIGLGSLIGIIVLVFLVYRSTLPLALALLSISTGLACAYVLTIALFGSIHLFSLVFGASLIGVSIDYAFHFLTDRLHAGKKWNSVVGIQQLFPAITLGLITSLIGYLGMLIAPFPGLQQLSLFSAIGLTAAYFTVVCWYPILASKPNQYNKVPMQRALSQWLLVWQQPLIRLVLPLSLLIAASFGVYMAKYDDDIRQLQALPHALQQQEREIKAITGVSGSQQLLLVRDSSEEGLLQKLETISTKLDKRNDFGGYQSISRYVPSQKRQQENYQLVKHLYQQQSEYYQSVIQQKTALDFSQQYQPLTIDGFLASPISDTVGFLWLGKIDDVFASVIAFNQEVNSTELQAFAADNHITYLNKAEEISRLFADYRHRITELLLFAYAAIFLLLLPRYKMKQAFLIVLPPFIAGCAGLAVTVLTGVPLNLFNLLALMLILGIGIDYTLFFAEQNKQSDDSHKESTLLAISLSALTTILSFGLLALSETQAIHSFGITVLTGIIVAWLLAPLSQQNKESKGYINTLSEKKDAS	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	61.56	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2400	2988	novobiocin
BGC0000837.1|APE_17 # 14282 # 14908 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.392	BGC0000837.1|APE_17 	14282	14908	+	Loose	230	25.7942	ramA	26.47	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGCATCATAAGGCCATAAAAGTCCGCCACCTTATAGCGCTTGTTCTATCCTTTCTTTTGATGGGATGTGCAGCAAAACCGGTAAAGCAACCCAACCAAGTAGAAGTATCACAAGGTCAGTTTATTACCTTACCTCAGCCTGAAGAGTATGGCAGTGACTTATCACTTAGTCAGTTAATCTCAGTTGAATGGCAAGGAAAAAAGAATCAACTTCCTGTTCAACTGCAACTGACAGGTAATGACTTGGTATTAGCTGGCTTTGCCTCATGGGGTTCTCGTTTATTAAGCTTAGATTATGATGGTCAAACATTAGATACTTACGTAATGGCAGGGCTAAGTGACACGCTACCACCGCCAGAGCAAGTGCTATTTAATGTCATGATTACCTTGTGGCCACTTGAAGCATGGCAAGAAAGTTTAACTAGCATTGGCTGGCAACTAAACGAACATGACAATCATAGAACATTAGTGACTGAATCAGGAAAAACAATCCTTGATGCTCGTTATGATGACATCACAGACAAATTAAGTGGTGAAATTGTGTTAACCAGTCCAGATTTTGGTTATGTCATAAAAATTAAAACGTTCTCGCATTCAAATACAACAACTCAAAATAATAACGGATAA	MHHKAIKVRHLIALVLSFLLMGCAAKPVKQPNQVEVSQGQFITLPQPEEYGSDLSLSQLISVEWQGKKNQLPVQLQLTGNDLVLAGFASWGSRLLSLDYDGQTLDTYVMAGLSDTLPPPEQVLFNVMITLWPLEAWQESLTSIGWQLNEHDNHRTLVTESGKTILDARYDDITDKLSGEIVLTSPDFGYVIKIKTFSHSNTTTQNNNG	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	167.74	gnl|BL_ORD_ID|1537|hsp_num:0	1665			3	198	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000837.1|APE_18 # 14914 # 16101 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.417	BGC0000837.1|APE_18 	14914	16101	+	Loose	750	133.65	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	31.34	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGTGACTTTCCTTTATATATACATGCGTGTGGCTCACATTCAGCCATGGGTAAAGAGGTTGATGAAATCCATCAAGTATTGAGTGGAAATAAAGCGCCATCAATGCATAAAGAGACAGGTTGGCTCAATAATGGAAAGGCAACAGTCGTTGGTAAAGCATTAGGTGAGTTACCTTTAGTTCCTGAGCATTTGGCTCATTGGGATACCAGAAATAATCAGCTTGTTTTGTCCGCTTTACAGCAAATCGAACCTCAAATTAACGCCGCAAAAGAGAAATACGGTTCAGATCGTATTGCTGTTATTGTTGGTACGAGTACTTCAGGGATCTCGGATGGTGAAGTCGCTTTAAAAGAGAAGATGGAGCAAGGGGCTTTTCCTGCTGGTTATAGCTATAAACAACAAGAGTTAGGAAACCCCGCGGATTTTATTGCTCAATATCTTGATATCAATGGACCAACGTATGCGATCTCAACCGCTTGTTCCTCAAGTGGTCGTGTTTTCTTATCAGCAAAGCGTTTATTAAAAGCAGGGTTTGTTGATGCGGTTATCGTTGGCGGTACTGACAGTTTATGCCGTTTAACATTAAATGGTTTCAACAGCCTAGAAGCACTATCAAATGAGTATTGTCTGCCGTTTAGTCCCAATCGAAAAGGGATAAACATTGGTGAAGCTAGCGCATATATGTTGTTAAGTGCAGAGCAAAAAGATTCTGATGATCCTATTGCTTTATTAGGAGCTGGAGATAGCTCAGATGCTCACCATATATCGGCCCCGCACCCTGAAGGAAAAGGGGCAATTGAAGCGATGAATAAAGCGCTAACAGATGCTGGTTTGGAACCTAAAGACATTGGTTATATTAATGCGCATGGAACCGCCACACCGCTGAATGATGCCATGGAATCTAAAGCCGTTCATGCGGTGTTTGGTCATTCAGTACCGGTGAGCTCAACAAAACCATTCACTGGGCACACATTAGGTGCCGCAGGTATCATTGAAGCAAGCATTTGTTGGCATATTTTAAAGTATAATTTACCGCTACCTAAGCAGATTAATGACGGACAGCAAGATGATGCACTGGCTGATATTCAGCTTGTGGTCGATCAACCACTAAGAAAAAAAGCCGTTATTAGTAATTCATTTGCCTTTGGCGGTAATAACATCAGTTTAATTTTTGGATGTATTTGA	MSDFPLYIHACGSHSAMGKEVDEIHQVLSGNKAPSMHKETGWLNNGKATVVGKALGELPLVPEHLAHWDTRNNQLVLSALQQIEPQINAAKEKYGSDRIAVIVGTSTSGISDGEVALKEKMEQGAFPAGYSYKQQELGNPADFIAQYLDINGPTYAISTACSSSGRVFLSAKRLLKAGFVDAVIVGGTDSLCRLTLNGFNSLEALSNEYCLPFSPNRKGINIGEASAYMLLSAEQKDSDDPIALLGAGDSSDAHHISAPHPEGKGAIEAMNKALTDAGLEPKDIGYINAHGTATPLNDAMESKAVHAVFGHSVPVSSTKPFTGHTLGAAGIIEASICWHILKYNLPLPKQINDGQQDDALADIQLVVDQPLRKKAVISNSFAFGGNNISLIFGCI	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	94.95	gnl|BL_ORD_ID|1968|hsp_num:0	1943			201	1242	isoniazid
BGC0000837.1|APE_20 # 16582 # 17307 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.430	BGC0000837.1|APE_20 	16582	17307	+	Loose	1200	25.7942	arnA	41.38	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAAGACAAGTATTAGTGACAGGCGCCAGTAAAGGCATTGGTCGCGCAATTTCAGAGCAACTAGCAAAGGATGGCTTTTATATTGTTGTTCATTATATGAGTGATAAAGCTGGCGCAGAGACAACGTTAGCAGCAATTCAAGAGCACGGTGGTGAAGGGCGCTTAATTCAGTTCGATATTAGTGACCGTGCACAATGTAAAGCGACACTTGAGAGTGATATCGAAACTCATGGTGCATATTATGGTGTGGTAAGTAATGCTGGCATTACTCGTGATACCGCTTTCCCTGCAATGACAGAAGAAGAGTGGGATGGCGTAATTCATACCAATTTAGACAGTTTTTATAATGTACTTCATCCTTGTGTTATGCCGATGGTTCAAAAGCGAAAAGGCGGTCGAATTGTGACGCTTGCATCGGTGTCAGGCATCATGGGTAACCGTGGTCAAACGAACTACAGCGCAGCAAAAGCTGGCGTTATTGGTGCAACTAAATCTCTTGCGTTAGAGCTAGCAAAACGAAAAATCACAGTAAACTGTGTTGCACCTGGCTTAATTGATACAGGCATGGTTGATGAGCATGTGAAAGAGCATGCATTGCCACAAGTACCACTTCGAAGAATGGGTGAACCAGAAGAAGTAGCCGGTTTAGTAAGTTACTTAATGTCAGATGTTGCGGGTTATGTGACTCGCCAAGTTATTTCAATTAATGGTGGTTTAGTATGA	MKRQVLVTGASKGIGRAISEQLAKDGFYIVVHYMSDKAGAETTLAAIQEHGGEGRLIQFDISDRAQCKATLESDIETHGAYYGVVSNAGITRDTAFPAMTEEEWDGVIHTNLDSFYNVLHPCVMPMVQKRKGGRIVTLASVSGIMGNRGQTNYSAAKAGVIGATKSLALELAKRKITVNCVAPGLIDTGMVDEHVKEHALPQVPLRRMGEPEEVAGLVSYLMSDVAGYVTRQVISINGGLV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	36.40	gnl|BL_ORD_ID|1513|hsp_num:0	1643			948	1035	polymyxin B
BGC0000837.1|APE_21 # 17304 # 18539 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.425	BGC0000837.1|APE_21 	17304	18539	+	Loose	275	27.335	AAC(6')-Iak	50.0	3003199	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAGTCGTCGTGTAGTCGTAACCGGAATGTCTGGTGTTACCGCTTTAGGTAGTGATTGGAACACCGTAGGCGAAAACCTACGTAAGTGTGAAAATGCCACTCAATATATGCCAAGCTTTGAAGTCTACGATGGTCTTAATACTAAGCTAGCAGCCCCTATTAATGATTTCACATTACCAAAGCACTATACCCGTAAAAAAATTCGTTCTATGGGACGTGTTTCTTTGTTATCTACCGTTGCTTCAGAGCAAGCCTTAGAGCAAAGTGGCCTTATTGGAAATGACATCTTAACCAATGGCCAAACAGGTATTGCCTTTGGTTCCTCAACCGGTTCTACCGATGCCGTTGGTGCTTTTGGTGTGATGCTTAATGAGAAATCAACTCGTGCTATTACGGCAACAACCTATGTGCAAATGATGCCACATACCGCAGCGGTTAACGTTGGTTTATTCTTTGGTTTACGTGGCCGAGTTATTCCAACAAGCAGCGCATGTACTTCAGGCAGCCAAGCGATTGGTTATGCTTATGAAGCGATTAAACACGGTTATCAAACGGCAATGGTTGCTGGTGGCGCAGAAGAATTATGCCCAACAGAATCAGCAGTATTTGATACATTATTCGCAACAAGTTTAAAAAACGATGCGCCAAAAACATCCCCAAGCCCATATGACCAAGATCGCGATGGTCTTGTTATTGGTGAAGGTGCTGGTGCTTTAGTTCTTGAAGAGTATGAACATGCTAAAGCTCGTGGCGCAACGATTTACGCAGAGCTAGTTGGTTTTGCAAGTAACTGTGATGCTGCCCATGTAACACAACCACAAATGGAAACCATGCAAATGTGTATGGAAATGTCGTTAAGGGATGCCAACTTAGCGCCAGAGAAAATTGGTTATGTTTCAGCGCATGGTACCGCAACAGAACGTGGTGATATAGCAGAAAGTACAGCAACAGAGAACGTATTTGGCTCATCAATGCCAATCAGTTCATTGAAGTCTTATTTTGGTCATACATTAGGTGCATGTGGTGCGATTGAAGCGTGGTTATCCATTGAGATGATGCGTAACAATTGGTTTAGCCCAACATTGAACTTAAATAATGTAGATGAGCGTTGCGGTAAGTTAGATTACATTACAGGTACAGGTCGTGAAATTGAGTGTGATTACATCATGAGTAACAACTTTGCTTTTGGTGGTATTAATACATCACTTATCTTTAAGCGCTGGACTGAAGAGTAG	MSRRVVVTGMSGVTALGSDWNTVGENLRKCENATQYMPSFEVYDGLNTKLAAPINDFTLPKHYTRKKIRSMGRVSLLSTVASEQALEQSGLIGNDILTNGQTGIAFGSSTGSTDAVGAFGVMLNEKSTRAITATTYVQMMPHTAAVNVGLFFGLRGRVIPTSSACTSGSQAIGYAYEAIKHGYQTAMVAGGAEELCPTESAVFDTLFATSLKNDAPKTSPSPYDQDRDGLVIGEGAGALVLEEYEHAKARGATIYAELVGFASNCDAAHVTQPQMETMQMCMEMSLRDANLAPEKIGYVSAHGTATERGDIAESTATENVFGSSMPISSLKSYFGHTLGACGAIEAWLSIEMMRNNWFSPTLNLNNVDERCGKLDYITGTGREIECDYIMSNNFAFGGINTSLIFKRWTEE	MTGSAATIRPAKAADAVAWAQLRLGLWPDADDPLETLVAALAEDAGAVFLACAAGGQAIGFAEVRLRHDYVNGTDSSPVGFLEGWYVQPQWQGRGVGRALLAAVRAWTRDAGCRELASDSRVEDVQAHAAHRACGFEETERVVYFRMPLEPSA	268.63	gnl|BL_ORD_ID|1761|hsp_num:0	1909			150	210	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
